- Provision of a COVID-19 Vaccine Booster Dose for Everyone Ages Five and Older (May 20, 2022)
- Modification of Johnson & Johnson (Janssen) COVID-19 Vaccine Usage (May 6, 2022)
- Provision of a Second mRNA COVID-19 Vaccine Booster Dose for Adults Ages 50+, for Persons with Immunocompromise Ages 12+, and for Janssen Recipients Ages 18+ (April 5, 2022)
- Modification of mRNA COVID-19 Vaccine Primary Series and Additional Dose Intervals (February 25, 2022)
- Modification of Moderna COVID-19 Vaccine Booster Dose Interval to Five Months (January 7, 2022)
- Expansion of Pfizer COVID-19 Vaccine Booster Dose to Persons 12 and Older (January 5, 2022)
- Modification of Johnson & Johnson (Janssen) Us Modification of Pfizer COVID-19 Vaccine Booster Dose Interval to Five Months for Persons Aged 16 and Older. Expansion of Third Dose to Immunocompromised Persons Aged 5 and Older (January 4, 2022)
- Modification of Johnson & Johnson (Janssen) Usage (December 16, 2021)
- Expansion of Pfizer Pediatric COVID-19 Vaccine to Ages 5 to 11 (November 3, 2021)
- Expectations for 'Open' COVID-19 Vaccination Points of Dispensing (January 22, 2021)
- Importance of Demographic Data Collection and Reporting to Ensure Equitable Access to COVID-19 Vaccines (February 12, 2021)
- Certified Professional Midwives in Birthing Centers (March 1, 2021)
- Revised Inventory Expectations for 'Open' COVID-19 Vaccination Points of Dispensing (May 7, 2021)
- Revised Eligibility Expectations for ‘Open’ COVID-19 Vaccination Points of Dispensing (May 28, 2021)
- Frequently Asked Questions: COVID-19 Vaccination Documentation (September 14, 2021)
- Expectations for Population Prioritization at Hospital-Based COVID-19 Vaccination Points of Dispensing (December 10, 2020)